Şunu aradınız:: rivaskularizzazzjoni (Maltaca - İngilizce)

rivaskularizzazzjoni
urgent

tvr – rivaskularizzazzjoni tal-arterja jew il-vina fil-mira
tvr - target vessel revascularization

dynastat ma ġiex studjat fi proċeduri ta ’ rivaskularizzazzjoni kardjovaskulari għajr proċeduri ta ’ coronary artery bypass graft.
dynastat has not been studied in cardiovascular revascularization procedures other than coronary artery bypass graft procedures.

dynastat ma ġiex studjat fi proċeduri ta’ rivaskularizzazzjoni kardjovaskulari għajr proċeduri ta’ cabg (coronary artery bypass graft).
dynastat has not been studied in cardiovascular revascularization procedures other than cabg (coronary artery bypass graft procedures).

għalkemm l-istudju falla fil-mira primarja tiegħu, li kienet magħmula mill-kawżi kollha ta’ mortalità, infart mijokariku mhux fatali, puplesija, sindromu koronarju akut, amputazzjoni maġġura tas-sieq, rivaskularizzazzjoni koronarja u rivaskularizzazzjoni tas-sieq, ir-riżultati ssuġġerixxu li m’hemmx periklu kardjovaskulari dwar l-użu ta’ pioglitazone fit-tul.
although the study failed regarding its primary endpoint, which was a composite of all-cause mortality, non-fatal myocardial infarction, stroke, acute coronary syndrome, major leg amputation, coronary revascularisation and leg revascularisation, the results suggest that there are no long-term cardiovascular concerns regarding use of pioglitazone.